To Assess Safety, Tolerability and Pharmacokinetics of BI 416970 in Healthy Male Volunteers

NCT02093819 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

60

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Placebo to BI 416970
DRUG: BI 416970

Sponsor

Boehringer Ingelheim